Nabokina SM, Ramos MB, Valle JE, Said HM. Regulation of basal promoter activity of the human thiamine pyrophosphate transporter SLC44A4 in human intestinal epithelial cells. Am J Physiol Cell Physiol 308: C750 -C757, 2015. First published February 25, 2015 doi:10.1152/ajpcell.00381.2014.-Microbiota of the large intestine synthesize considerable amount of vitamin B1 in the form of thiamine pyrophosphate (TPP). There is a specific high-affinity regulated carrier-mediated uptake system for TPP in human colonocytes (product of the SLC44A4 gene). The mechanisms of regulation of SLC44A4 gene expression are currently unknown. In this study, we characterized the SLC44A4 minimal promoter region and identified transcription factors important for basal promoter activity in colonic epithelial cells. The 5=-regulatory region of the SLC44A4 gene (1,022 bp) was cloned and showed promoter activity upon transient transfection into human colonic epithelial NCM460 cells. With the use of a series of 5=-and 3=-deletion luciferase reporter constructs, the minimal genomic region that required basal transcription of the SLC44A4 gene expression was mapped between nucleotides Ϫ178 and ϩ88 (using the distal transcriptional start site as ϩ1). Mutational analysis performed on putative cis-regulatory elements established the involvement of ETS/ ELF3 [E26 transformation-specific sequence (ETS) proteins], cAMPresponsive element (CRE), and SP1/GC-box sequence motifs in basal SLC44A4 promoter activity. By means of EMSA, binding of ELF3 and CRE-binding protein-1 (CREB-1) transcription factors to the SLC44A4 minimal promoter was shown. Contribution of CREB into SLC44A4 promoter activity was confirmed using NCM460 cells overexpressing CREB. We also found high expression of ELF3 and CREB-1 in colonic (NCM460) compared with noncolonic (ARPE19) cells, suggesting their possible contribution to colon-specific pattern of SLC44A4 expression. This study represents the first characterization of the SLC44A4 promoter and reports the importance of both ELF3 and CREB-1 transcription factors in the maintenance of basal promoter activity in colonic epithelial cells.
SLC44A4; promoter; transcription regulation; thiamine pyrophosphate; colonocytes THIAMINE (VITAMIN B1) SERVES an essential role in cellular metabolism via its involvement mainly in the form of thiamine pyrophosphate (TPP) in critical metabolic pathways including carbohydrate and energy metabolism, mitochondrial ATP synthesis, and maintaining normal cellular redox state (reviewed in Refs. 3, 4, 21, 22) . This important micronutrient cannot be synthesized de novo in mammalian cells and thus has to be obtained through dietary and microbiota-generated sources. Dietary thiamine exists mainly in the form of TPP, which converts to free thiamine in the small intestine by the action of abundant phosphatases. This is followed by uptake of free thiamine by enterocytes via a specific carrier-mediated process that involves the well-characterized high-affinity thiamine transporter-1 and -2 (THTR-1 and THTR-2) (6, 19, 20, 24, 27) . Bacterial sources of thiamine refer to the vitamin that is generated by the colonic microbiota, which exists in the free and the diphosphorylated (TPP) forms (2, 7, 8, 15) . Studies from our laboratory have shown that both forms of the vitamin can be captured by colonic epithelial cells (13, 14, 23) . Free thiamine can be taken up by colonocytes via a specific and highly efficient process with characteristics that closely resemble those for the thiamine uptake process occurring in the small intestine (reviewed in Refs. 21, 22) . Our recent studies have shown the existence of a specific and high-affinity carriermediated uptake process for the TPP form of the vitamin by human colonocytes (13) that involves a colonic TPP transporter, TPPT (product of the SLC44A4 gene) (14) . Human TPP transporter (hTPPT) is a multitransmembrane (with at least 12 transmembrane domains) protein of 710 amino acids that is highly conserved across mammals. hTPPT is expressed predominantly at the apical domain of the plasma membrane in polarized epithelial cells (14) . hTPPT has a very restricted tissue/cell type distribution, being highly expressed in the colon (but not in other parts of gastrointestinal tract), prostate, trachea, and lungs (14) . Nothing is currently known about how the TPPT system is regulated at any level. Meantime knowledge about cellular and molecular mechanisms of TPPT regulation is important since this transporter plays a role in the absorption of the microbiota-generated TPP in the large intestine and thus may contribute toward overall-body thiamine nutrition and especially toward the cellular nutrition of the local colonocytes. Thus in this study we aimed at examining the molecular mechanisms of SLC44A4 gene expression with a focus on the basic transcriptional activity of the SLC44A4 gene. We cloned the 5=-regulatory region of SLC44A4 gene, identified the SLC44A4 minimal promoter region, and characterized transcription factors important for basal promoter activity in colonic cells. Our results show an important role for the ELF3 and cAMP-responsive element (CRE)-binding protein-1 (CREB-1) transcriptional factors in regulating the basal activity of the SLC44A4 promoter in colonic cells.
MATERIALS AND METHODS
Materials. Synthetic oligonucleotides were obtained from Sigma Genosys (Woodlands, TX). Anti-ELF3, anti-CREB-1, anti-SP1 antibody, and normal rabbit IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The CREB expression plasmid pRC/ RSV-CREB and its empty vector pRC/RSV were kindly provided by Dr. Richard Goodman (5) . Routine biochemicals, cell culture reagents, and transfection reagents were all of molecular biology quality and were purchased from Fisher Scientific (Tustin, CA), Sigma (St. Louis, MO), and Life Technologies (Rockville, MD). The NCM460 cell line was from INCELL (San Antonio, TX). ARPE19 cells were purchased from American Type Culture Collection (Manassas, VA).
5=-Rapid amplification of the cDNA ends. The rapid amplification of the cDNA ends (RACE) technique and 5=-RACE kit (Life Technologies) was used for transcriptional start site (TSS) determination in human colonic NCM460 cells. Primers were designed based on the sequence information for the transcript variants 1, 2, and 3 of the human SLC44A4 available from GenBank (accession nos. NM_025257, NM_001178044, and NM_001178045, respectively). The first-strand cDNA was synthesized using 2 g of total RNA and the gene-specific reverse primer 5=-CCTGGCAGACAAAAGTTC-CTGT-3=, located in exon 7. A subsequent amplification was performed by using the gene-specific reverse primers 5=-GGGGCACT-GTAGGCCGTTCTCA-3= and 5=-GCTGGACAGGATGCAGCT-GA-3= (both from exon 6) and Abridged Anchor forward primer supplied by manufacturer. PCR products were cloned into the pGEM-T Easy vector (Promega, Madison, WI). The DNA sequences were determined by the Laragen Sequencing Facility (Los Angeles, CA).
Cloning of the 5=-regulatory region for the SLC44A4 gene. Design of PCR cloning primers was based on the sequence information for the SLC44A4 gene available from GenBank (accession no. NG_023058.1). One-hundred nanograms of human genomic DNA (Clontech, Mountain View, CA) were amplified by PCR using two gene-specific primers (forward: 5=-CATCCTCAGTTGAAGTTT-GATG-3= and reverse: 5=-CAGGGACACAGTACTCTCCTTAG-3=). PCR was performed using the following conditions: denaturation at 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 1 min, annealing at 58°C for 1 min, extension at 72°C for 3 min, and then a final extension at 72°C for 10 min. The PCR product of the expected size of 1,022 bp was cloned into the pGEM-T Easy vector and then subcloned into the XhoI/HindIII sites of pGL3-Basic luciferase reporter vector (Promega) upstream of the luciferase gene. The DNA sequence of the final construct was verified by the Laragen Sequencing Facility.
Construction of SLC44A4 promoter-luciferase reporter plasmids. 5=-And 3=-deleted constructs were generated by PCR using genespecific primers (Table 1) , followed by subcloning of the PCR fragments into the polycloning site of pGL3-Basic vector after digestion of both with XhoI and HindIII. Mutating of the putative cisregulatory elements inside the SLC44A4 minimal promoter region was performed by site-directed mutagenesis utilizing the QuickChangeII XL site-directed mutagenesis kit. Primers containing mutated nucleotides are depicted in Table 2 . The DNA sequences of the final constructs were verified by the Laragen Sequencing Facility.
Cell culture, transfection, and reporter gene assay. NCM460 cells used in our studies are derived from human colonic epithelium and have a nontransformed phenotype (thus they may serve as a better model for the intestinal epithelium compared with cell lines obtained from colorectal tumors). These cells have been used previously in a variety of physiological investigations with similar data to those obtained with native human colonic preparations (13) . NCM460 cells were maintained in Ham's F-12 culture medium supplemented with 20% (vol/vol) FBS, penicillin (100,000 U/l), and streptomycin (10 mg/l). ARPE19 cells were maintained in DMEM media supplemented with 10% (vol/vol) FBS and the same antibiotics. At ϳ90% confluence cells were transfected with 2 g of test promoter construct and 100 ng of the Renilla transfection control plasmid Renilla luciferasethymidine kinase (pRL-TK; Promega) with the Lipofectamine 2000 (Invitrogen, Carlsbad, CA). In experiments for CREB overexpression, cells were also cotransfected with varying amounts of pRC/RSV-CREB (or empty vector pRC/RSV-control). Forty-eight hours after transfection Renilla-normalized firefly luciferase activity was measured by using the Dual Luciferase Assay System (Promega). Data are presented as means Ϯ SE of multiple independent experiments and given as fold over pGL3-Basic expression set arbitrarily at one.
Electrophoretic mobility shift assay. Nuclear extract from NCM460 cells was obtained with the commercially optimized NE-PER nuclear and cytoplasmic extraction reagents (Thermo Scientific Pierce, Rockford, IL) according to the manufacturer's instructions. To identify the transcription factors that bind to the ETS/ELF3 [E26 transformationspecific sequence (ETS) proteins] motif, a 21-bp region (5=-GAGAA-GAAGGAACTAGAGTGT-3=) and a 36-bp region (5=-GCTGGGCA-CAAAGTTGAGAAGAAGGAACTAGAGTGT-3=) spanning a sequence between Ϫ88 and Ϫ68 nucleotides and between Ϫ103 and Ϫ68 nucleotides, respectively, were used in electrophoretic mobility shift assay (EMSA). To study transcription factors that bind to CRE and SP1/GC box (at-21/Ϫ18), a 40-bp region between Ϫ61 and Ϫ22 (5=-GACCACAGGCGGGGGTGGGGCTGTGACGTGTGGGAG-GGCG-3=) and a 42-bp region between Ϫ47 and Ϫ6 (5=-GTGGGGCTGTGACGTGTGGGAGGGCGGGGCGGGCAGCAG-GTG -3=) were used in EMSA. Promoter fragment was biotin-labeled using biotin 3=-end DNA labeling kit (Thermo Scientific Pierce). EMSA was performed using LightShift Chemiluminescent EMSA kit (Thermo Scientific Pierce) according to the manufacturer's instructions. Binding reactions were carried out in 20 l containing 5 g of nuclear extract, 20 fmol of biotin end-labeled DNA fragment, and 50 ng/l poly (dI·dC) and incubated for 20 -30 min at room temperature. Oligonucleotide competition analysis was conducted with a molar excess of unlabeled SLC44A4 DNA fragments. To identify transcription factors involved, the nuclear extract was pretreated with 1 g anti-ELF3, anti-CREB-1, anti-SP1 antibody, or 1 g normal rabbit IgG for 30 min at 4°C. DNA-protein complexes were separated on 6% DNA retardation gel (Invitrogen Life Technologies), followed by electrophoretic transfer of binding reactions to nylon membranes and crosslink of transferred DNA to membrane. Biotin-labeled DNA was detected by chemiluminescence using Chemiluminescent Nucleic Acid Detection Module (Thermo Scientific Pierce).
Western blot analysis. Nuclear extracts were obtained from NCM460 and ARPE19 cells with the commercially optimized NE-PER nuclear and cytoplasmic extraction reagents (Thermo Scientific Pierce). Proteins were separated in NuPAGE 4 -12% Bis-Tris gradient minigels (Invitrogen), transferred onto immobilon polyvinylidene difluoride membrane (Fisher Scientific), and subjected to immunostaining. Anti-ELF3 and anti-CREB-1 antibodies and anti-lamin B Table 1 . Primers used in PCR for generating the truncated SLC44A4 promoter constructs
XhoI and HindIII restriction sites are shown in bold and underlined. Table 2 . Primers used in site-directed mutagenesis of the SLC44A4 promoter
Location of mutation is shown in bold and underlined. See text for definitions.
antibody (control for loading) served as primary antibodies. The secondary antibodies were anti-mouse IRDye-800 and anti-rabbit IRDye-800 antibody for detection protein of interest. To detect lamin B, anti-goat IRD-680 antibody was used as a secondary antibody. Immunoreactive bands were visualized using the Odyssey infrared imaging system (LI-COR Bioscience, Lincoln, NE).
Statistical analysis. Promoter assays, Western blot analyses, and EMSA were performed on three or more separate occasions with comparable results. Data were analyzed by the one-way ANOVA followed by Tukey's honestly significant difference post hoc test. P Յ 0.05 was considered statistical significant in all tests. Data (Western blot and EMSA) presented in this article are from a representative set of experiments.
RESULTS

Mapping of TSS of the SLC44A4 gene and cloning of the SLC44A4 promoter.
The RACE technique was performed to map the TSS of SLC44A4 in human colonic epithelial NCM460 cells. The 5=-ends of SLC44A4 cDNA with an ϳ400 bp in length were amplified, cloned, and sequenced. The sequencing results indicated existence of four distinct TSSs (all located inside exon 1 upstream of the translation start site) that were mapped to C at 5,028, C at 5,049, A at 5,050, and A at 5,057 position using RefSeqGene information for the SLC44A4 gene deposited in GenBank (accession no. NG_023058). In our further data presentation the C of distal TSS will be mapped as ϩ1.
A 1,022-bp 5=-flanking region of the human SLC44A4 gene was amplified and cloned from human genomic DNA. Sequence analysis revealed the identity of the cloned genomic DNA fragment. The cloned fragment (mapped as Ϫ829/ϩ193) contained exon 1 of the SLC44A4 gene and part of intron 1 (114-bp downstream from exon 1) and extends to Ϫ802-bp upstream of exon 1. Four identified TSSs and the translation initiation ATG site for isoform 1 (i.e., predominantly expressed in colon) were present in the cloned fragment. To determine its functionality, the 5=-flanking region of human SLC44A4 gene was subcloned into the promoterless plasmid vector pGL-3 basic and examined in a transient transfection experiment, using the NCM460 cells. Determination of Renilla-normalized firefly luciferase activity (Fig. 1) showed that the cloned putative promoter fragment possesses significant (P Ͻ 0.01; ϳ11-fold above pGL-3 basic vector) activity.
Identification of the minimal SLC44A4 promoter. To identify the minimal genomic region required for SLC44A4 gene expression, a series of 5=-and 3=-deletion mutant luciferase reporter constructs were generated and used for transient transfection of NCM460 cells. The results of reporter activity determination (Fig.  1) showed that the construct Ϫ278/ϩ88 (with only 366 bp in length), which was generated as a result of truncations from both 5=-and 3=-ends, possessed promoter activity significantly higher (ϳ3-fold) than that observed for the cloned Ϫ829/ϩ193 promoter fragment. We concluded that there are possible transcriptional repressor(s) located upstream (between nucleotides Ϫ829 and Ϫ278) or downstream (between nucleotides ϩ88 and ϩ193) of the TSSs. Further 5=-deletion analysis using constructs with a variable 5=-end, but a common 3=-end at nucleotide ϩ88, showed that deletion of 100 nucleotides up to Ϫ178 did not reduce a promoter activity, whereas ablation of an additional 100 nucleotides up to Ϫ78 dramatically reduced a promoter activity (Fig. 1) . Construct Ϫ178/ϩ88 (with 266 bp in length) contained all four identified TSSs and conferred ϳ300% of the activity of the cloned 1,022-bp promoter fragment. Thus we concluded that the 5=-flanking region of SLC44A4 gene between nucleotides Ϫ178 and ϩ88 is required for basal promoter activity and will be designated as a minimal promoter in our further data presentation.
Establishment of ETS, CRE, and SP1/GC-box sequence motifs as the key regulatory elements in SLC44A4 promoter
activity. The MatInspector computational software (www. genomatix.de) was used to search for transcription factor binding sites inside the identified minimal promoter. Schematic diagrams depicting the SLC44A4 gene structure and the genomic sequence of the SLC44A4 minimal promoter region with location of the putative cis-regulatory elements are presented at Fig. 2 . In our initial search we focused on the promoter region from Ϫ178 to Ϫ78 bp since very low levels of reporter activity was detected for the Ϫ78/ϩ88 construct suggesting that the important elements are located upstream of Ϫ78 nucleotide. The analysis revealed that a region between nucleotides Ϫ178 and Ϫ78 contains several putative cis-regulatory elements for transcriptional factors such as activator protein 2 (AP2), ETS/ELF3 [E26 transformation-specific sequence (ETS) proteins], Kruppel-like zinc finger protein 219, GC-rich Smad1/5 transcriptional factor, KLF15 (kidneyenriched Kruppel-like factor), KRAB-containing zinc finger protein 300, and hepatic nuclear factor 4 (HNF4) (Fig. 2B) . In the case of ETS/ELF3 transcriptional factor, two putative sites were identified, distal and proximal, with ETS cores separated by 64 bp.
To determine the contribution of these putative cis-elements in promoter functionality, the effect of mutations in the core sequence elements on promoter activity was studied. The results (Fig. 3A) showed that none of the mutations tested except mutation in the proximal ETS site led to a significant (P Ͻ 0.01) reduction in promoter activity. In the case of mutating the first three nucleotides in the proximal ETS core GGAA, the reduction in promoter activity was ϳ55% compared with activity of the wild-type promoter. Importantly, a core GGAA sequence for the proximal ETS site was cut in the middle while generating the truncated construct Ϫ78/ϩ88 that resulted in a lack of this cis-element in Ϫ78/ϩ88 construct.
To further confirm the observation on importance of the proximal ETS site, we generated a truncated construct Ϫ88/ ϩ88 where the ETS site, including both core and flanking 178/+88 78/+88 28/+88 Fig. 1 . Activity of the SLC44A4 promoter in NCM460 cells and transient transfection assays with deletion constructs. The 5=-and 3=-deletions were generated for the cloned 5=-regulatory region of the SLC44A4 (Ϫ829/ϩ193) as described in MATERIALS AND METHODS. Reporter plasmids were transiently transfected into NCM460 cells for luciferase assays. Data are reported as relative firefly luciferase activity normalized to Renilla luciferase activity. Each value represents the means Ϯ SE of at least 3 independent experiments, each performed in triplicate.
nucleotides, was preserved. The results (Fig. 3B) showed that restoration of the proximal ETS site in the promoter construct led to a significant (P Ͻ 0.01) increase in promoter activity. Indeed, the reporter activity detected in cells transfected with the Ϫ88/ϩ88 construct was lower but comparable to that of the intact minimal promoter. In contrast, a Ϫ78/ϩ88 construct showed very low level of basal promoter activity. Since mutations of the proximal ETS/ELF3 site did not lead to a complete abolishment of promoter activity, the possibility exists that transcriptional factors other than ELF3 are involved The mutated minimal promoter constructs in pGL3-Basic were transiently expressed in NCM460 cells for luciferase assays. WT, wild-type promoter fragment. See RESULTS for additional definitions. Data are reported as relative firefly luciferase activity normalized to Renilla luciferase activity and represent means Ϯ SE of at least 3 independent experiments, each performed in triplicate. B: transient transfection assays with truncated mutants of the minimal promoter region lacking or containing proximal ETS/ELF3 sequence. The experiment was performed as described in A. *P Ͻ 0.01. in basal promoter regulation. To gain more insight into this possibility, we further extended our search for transcription factor binding sites and subjected a promoter region downstream from the proximal ETS/ELF3 site to the MatInspector analysis. The search (Fig. 2B) revealed the presence of multiple cis-regulatory elements, such as SP1/GC-boxes shared with KLF-like motifs, CCAAT box (NF-Y binding site), and CRE. To elucidate the importance of these promoter elements, sitedirected mutagenesis was performed. The results (Fig. 4) showed that mutations within the core of CRE site and SP1/ KLF15 motif significantly (P Ͻ 0.01) decreased promoter activity; in contrast mutations in the core of CCAAT/NF-Y box showed no significant effect on promoter activity. Taken together, our findings from the deletion and mutational analysis suggest a key role of the proximal ETS, CRE, and SP1/GC-box sequence motifs in basal activity of the SLC44A4 promoter.
ELF3 and CREB-1 bind to the SLC44A4 promoter.
To further analyze transcription factor binding to the SLC44A4 promoter, the multiple regions of the minimal promoter were subjected to EMSA. A 21-bp region and a 36-bp region spanning the sequence between Ϫ88 and Ϫ68 nucleotides and between Ϫ103 and Ϫ68 nucleotides, respectively, were used to identify the transcription factors that bind to the proximal ETS motif with its core at Ϫ80/Ϫ77 bp. As shown in Fig. 5A , the addition of NCM460 cell nuclear extract to labeled oligonucleotide probes generated a single major DNA-protein complex with the same mobility for both probes (lanes 1 and 3; additional minor complexes were also detected for the 36-bp probe). This complex was effectively competed by a molar excess of unlabeled probe (lanes 2 and 4) . The ETS/ELF3 cis-regulatory element can serve as a binding site for ELF3 transcription factor. ELF3 is a member of ETS protein family with a unique epithelium-restricted pattern of expression (with particular high expression in the epithelium of the gastrointestinal tract) that is known to specifically bind to the ETS sequence motifs (GGAA/T) within the target gene promoter and transregulate it (1, 9 -11, 16 -18, 28) . Thus next we studied if ELF3 was able to bind to the SLC44A4 promoter. As can be seen from Fig. 5B , the addition of antibodies specific to ELF3 (lane 4) (but not normal IgG or unrelated anti-SP1 antibodies, negative controls, lanes 2 and 3) inhibited the formation of this major DNA/protein complex resulting in its disappearance. These data indicate that the proximal ETS cis-regulatory element (with its core at Ϫ80/Ϫ77 bp) is a target for ELF3 transcriptional factor binding.
To study transcription factors that bind to CRE (at Ϫ38/Ϫ35 bp) and SP1/GC box (at Ϫ21/Ϫ18 bp), a 40-bp region between Ϫ61 and Ϫ22 and a 42-bp region between Ϫ47 and Ϫ6 were used in EMSA. Both these DNA fragments contain CRE motif (core and flanks); in addition to CRE a 42-bp fragment also contained a SP1/GC box (at Ϫ21/Ϫ18 bp). As shown at Fig. 6 , for both fragments two major specific DNA/protein complexes . DNA/protein profile from EMSA using SLC44A4 promoter region with the proximal ETS/ELF3 (at Ϫ80/Ϫ77 bp) sequence. Gel shift assay was performed with the nuclear extracts from NCM460 cells and biotin-labeled 21-and 36-bp regions of the SLC44A4 promoter spanning a sequence between Ϫ88 and Ϫ68 and between Ϫ103 and Ϫ68, respectively, as described in MATERIALS AND METHODS. A: to establish specificity of the DNA/protein complexes, an assay was conducted with (a 30-fold molar excess) or without identical unlabeled DNA fragments. The major DNA/protein complex is indicated with arrow. B: to study a binding of ELF3 transcription factor, binding reaction was performed in the absence of antibody, in the presence of nonspecific IgG, in the presence of unrelated antibody against SP1, or in the presence of antibody against ELF3. Arrow indicates major specific DNA/protein complex.
(complex 1 and 2; lanes 2 and 6) were detected (both inhibited by a molar excess of unlabeled probe; lanes 3 and 7) when incubated with NCM460 cell nuclear extract. CRE is known to serve as a binding site for CRE-binding proteins, CREB-1 and CREB-2, and activating transcription factors (ATFs) (reviewed in Refs. 12, 25, 26) . We then studied possible involvement of one of these proteins, CREB-1, in binding to the SLC44A4 promoter. In the case of Ϫ61/Ϫ22 promoter fragment, CREB-1-specific antibodies completely prevented formation of both complexes (lane 4). In the case of the Ϫ47/Ϫ6 promoter fragment, CREB-1-specific antibodies also completely prevented formation of the upper complex 1 and inhibited formation of complex 2 [the band corresponding to complex 2 (lane 8) had a lesser intensity compared with when antibodies were not added to the reaction mixture (lane 6)]. Thus we concluded that complexes 1 and 2 are composed of CREB-1 protein. SP1-specific antibodies had no effect on the mobility of complexes 1 and 2 as well as their formation (the same pattern was detected; lane 9). These data suggest that CRE inside the minimal SLC44A4 promoter is a cis-regulatory element required for CREB-1 binding, whereas SP1/GC box (at Ϫ21/ Ϫ18 bp) is unable to bind SP1 protein.
CREB transcription factor contributes to SLC44A4 promoter activity. To further study the involvement of CREB in the regulation of the SLC44A4 promoter activity, we determined the effect of CREB overexpression on promoter activity in NCM460 cells. The results of luciferase assays (Fig. 7) showed that the addition of the CREB expression vector led to a significant (P Ͻ 0.01) and dose-dependent increase in promoter activity. We also studied the effect of modulators of the cAMP/PKA-dependent pathway, IBMX (an inhibitor of cAMP phosphodiesterase) and H-89 (a PKA inhibitor) (50 M for both; 24 hr), on promoter activity. Treatment of NCM460 cells transiently transfected with CREB expression vector with the cAMP enhancer IBMX further significantly (P Ͻ 0.01) increased promoter activity suggesting CREB stimulation under these conditions. In contrast, the PKA inhibitor H-89 was found to significantly (P Ͻ 0.01) reduce promoter activity in cells overexpressing CREB.
ELF3 and CREB-1 are involved in colon-specific regulation of SLC44A4 gene expression. As a first step into gaining knowledge on cell-and tissue-specific regulation of transcription of SLC44A4, we compared the levels of SLC44A4 promoter activity as well as the expression levels of transcription factors important for promoter functionality in NCM460 cells (colonic cells with high SLC44A4 expression) and ARPE19 cells (retinal cells with low SLC44A4 expression) (14) . As can be seen from Fig. 8A , reporter activity detected in NCM460 cells transfected with the Ϫ829/ϩ193 (cloned 5=-regulatory region) and Ϫ178/ϩ88 (minimal promoter) constructs is significantly (P Ͻ 0.01) higher than that detected in ARPE19 cells. We then estimated expression levels of CREB-1 and ELF3 by Western blot analysis using specific antibodies and nuclear extracts prepared from NCM460 and ARPE19 cells. The results showed that CREB-1 and ELF3 transcription factors are highly expressed in nuclei of NCM460 cells with very negligible expression in ARPE19 cells (Fig. 8B) . These data suggest possible involvement of ELF3 and CREB-1 in cell-specific mechanisms of transcriptional control of SLC44A4 gene.
DISCUSSION
There is no knowledge about the transcriptional regulation of the SLC44A4 gene. To address this issue, we cloned the Nuclear extract -+ + + - Both   Fig. 6 . DNA/protein profile from EMSA using SLC44A4 promoter region with the cAMP-responsive element (CRE) (at Ϫ38/Ϫ35 bp) sequence. Gel shift assay was performed with the nuclear extracts from NCM460 cells and 2 biotin-labeled regions of the SLC44A4 promoter spanning a sequence between Ϫ61 and Ϫ22 and between Ϫ47 and Ϫ6, respectively, as described in MATERIALS AND METHODS. A 100-fold molar excess of unlabeled fragment (self) was used to establish specificity of the DNA/protein complexes. Binding reaction was performed in the absence of any antibody or in the presence of antibody against CRE-binding protein-1 (CREB-1), SP1, or combination of both CREB-1 and SP1 (both). Arrows and numbers indicate 2 major DNA/ protein complexes. 5=-regulatory region of the SLC44A4 gene, established the basal promoter region, and identified key transcriptional factors that are required for basal promoter activity. Also, we demonstrated the elevated expression level of these transcriptional factors in colonic cells that could serve in mechanisms of cell-specific regulation of SLC44A4 expression. The human SLC44A4 gene spans a region of ϳ16 kb on chromosome 6 and consists of 22 exons. Two alternatively spliced transcript variants of the human SLC44A4, i.e., transcript variant 1 and 3, differing in their 5=-ends were previously detected in colonic cells with major expression of variant 1 (14) . We cloned a genomic region of 1,022-bp from human chromosome 6 upstream of the translation start site for SLC44A4 and evaluated its ability to serve as a promoter. Promoter activity of the cloned DNA fragment was found to be significant, and its further characterization resulted in the identification of the minimal promoter region of a 266-bp in length. The minimal promoter lacked the typical TATA motif, was enriched in GC nucleotides, and contained a variety of putative cis-regulatory elements.
The MatInspector computational analysis of the binding sites for transcriptional factors inside the minimal SLC44A4 promoter predicted the presence of multiple cis-regulatory elements that could potentially serve as the targets for basal, inducible, as well as cell-specific transcriptional factors. Our mutational analysis performed on cis-elements showed the importance of the ETS/ ELF3 and CRE motifs in maintenance of basal promoter activity in NCM460 cells. Among two putative ETS/ELF3 cis-elements, only the proximal (but not distal) ETS/ELF3 cis-element appears to contribute to promoter activity.
The ETS/ELF3 cis-regulatory element represents a binding site for the ELF3 transcription factor. ELF3 belongs to the ETS [E26 transformation-specific sequence (ETS)] transcription factor family that is known to specifically bind to the ETS sequence motifs [GGA(A/T)] within the target gene promoter and transregulate it (1, 9 -11, 16 -18, 28) . ELF3 has a unique epithelium-restricted pattern of expression under basal conditions and is known to be involved in the regulation of a wide range of normal physiological processes, with an essential role in gut development (16) . It is expressed in a variety of epithelial tissues, with particularly strong expression in the small intestine and colon (17) . Binding of ELF3 to the SLC44A4 promoter through its proximal ETS (with its core at Ϫ80/Ϫ77 bp) was demonstrated by EMSA study. The ELF3-specific antibody was clearly shown to inhibit the formation of the specific DNA/protein complex suggesting a role for ELF3 in basal promoter functioning.
The CRE is known to be a target for the binding of proteins that belong to the basic leucine zipper (bZIP) domain ATF/CREB family (12, 25, 26) . The ATF/CREB family includes CREbinding proteins, CREB-1 and CREB-2, and activating transcription factors (ATFs). Our EMSA study using CREB-1 specific antibody and two different promoter fragments (both containing CRE site) clearly demonstrated that CREB-1 binds to the SLC44A4 promoter through its CRE site. CREB is a well-characterized phosphorylation-dependent transcription factor that is expressed in numerous tissues and involved in a variety of cellular processes (12, 25, 26) . Activation of CREB through its phosphorylation at Ser133 is achieved by various signaling pathways, including a cAMP-dependent protein kinase A. Activated CREB interacts with the other coactivators (CREB-binding protein or p300) and activates transcription of the CREB-responsive genes (12, 25, 26) . The evidence for CREB contribution into SLC44A4 promoter functionality was obtained in our studies with the CREB expression plasmid. NCM460 cells transiently transfected with the CREB expression plasmid demonstrated a significant increase in SLC44A4 promoter activity. Furthermore, the capacity of CREB to enhance promoter activity appears to be phosphorylation-dependent since compounds altering cAMP level and PKA activity were found to have a prominent effect on promoter activity. In addition, our findings that ELF3 and CREB are transcriptional factors both involved in transactivation of the SLC44A4 promoter is of special interest since there is experimental evidence that CREB-binding protein (CBP) and ELF3 are the interacting proteins (28) . A possibility exists that p300/CBP (known coactivator of CREB) also positively modulates ELF3 function by serving as its transcriptional coactivator.
The SLC44A4 mRNA is highly expressed in a limited number of human tissues, such as colon, prostate, trachea, and lungs, with no or weak expression in other parts of gastrointestinal tract as well as other tissues/cells (14) . The cell and tissue specificity of expression of any given gene is known to be mediated via a variety of mechanisms, including different levels of basal and cell-specific transcription factors. To determine, if this is a case for the SLC44A4 gene, we compared the expression levels of ELF3 and CREB-1 in NCM460 cells (colonic cells with high SLC44A4 expression; Ref. 14) and ARPE19 cells (retinal cells with low SLC44A4 expression; Ref. 14) and found that ELF3 and CREB-1 expression levels are considerably higher in nuclei of NCM460 cells than those of ARPE19 cells. Thus there is a possibility that ELF3 and CREB-1 participate in cell-specific mechanisms of transcriptional control of SLC44A4 gene. Further studies will be directed at characterizing precisely their roles in this context. In addition, whether other mechanisms, such as epigenetic mechanisms via promoter methylation and histone modifications, are involved in cell-specific pattern of SLC44A4 gene expression will be further investigated. In summary, this study represents the first characterization of the SLC44A4 promoter and reports the importance of ELF3 and CREB-1 transcription factors in the maintenance of basal promoter activity in colonic epithelial cells. These findings should serve as a base for future investigations into how physiological (vitamin deficiency and oversupplementation, ontogeny, differentiation, etc.) and pathophysiological (exposure to entero-pathogenic bacteria, colonic inflammation, chronic exposure to alcohol, diabetes mellitus, etc.) conditions affect transcription of this important human gene. 
